SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-19-007194
Filing Date
2019-02-13
Accepted
2019-02-13 16:25:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv513394_sc13ga.htm SC 13G/A 53535
  Complete submission text file 0001144204-19-007194.txt   55051
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43329 | Film No.: 19597560
SIC: 2834 Pharmaceutical Preparations

Mailing Address 150 NORTH RIVERSIDE PLAZA CHICAGO IL 60606
Business Address 150 NORTH RIVERSIDE PLAZA CHICAGO IL 60606 312-236-1600
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by) CIK: 0001644956 (see all company filings)

IRS No.: 472614791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A